Patents by Inventor Ditte Lovatt

Ditte Lovatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transcriptome in vivo analysis
    Patent number: 9540680
    Abstract: The invention provides compositions and methods that permit a hybrid nucleic acid molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 10, 2017
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James Eberwine, Ditte Lovatt, Julia Richards, Ivan Dmochowski, Brittani Ruble
  • Transcriptome in vivo analysis
    Patent number: 9540634
    Abstract: Provided are compositions and methods that permit a hybrid nucleic acid-peptide molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: January 10, 2017
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James Eberwine, Ditte Lovatt, Julia Richards, Ivan Dmochowski, Brittani Ruble
  • Transcriptome In Vivo Analysis
    Publication number: 20130273537
    Abstract: The invention provides compositions and methods that permit a hybrid nucleic acid molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: James Eberwine, Ditte Lovatt, Julia Richards, Ivan Dmochowski, Brittani Ruble
  • TRANSCRIPTOME IN VIVO ANALYSIS
    Publication number: 20130267678
    Abstract: Provided are compositions and methods that permit a hybrid nucleic acid-peptide molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
    Type: Application
    Filed: June 7, 2011
    Publication date: October 10, 2013
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: James Eberwine, Ditte Lovatt, Julia Richards, Ivan Dmochowski, Brittani Ruble